Biogen Inc Stock Performance

BIIB Stock  USD 127.85  5.17  4.21%   
Biogen has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.14, which signifies a somewhat significant risk relative to the market. Biogen returns are very sensitive to returns on the market. As the market goes up or down, Biogen is expected to follow. Biogen Inc right now shows a risk of 1.96%. Please confirm Biogen Inc jensen alpha, maximum drawdown, semi variance, as well as the relationship between the sortino ratio and potential upside , to decide if Biogen Inc will be following its price patterns.

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biogen Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, Biogen may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more

Actual Historical Performance (%)

One Day Return
(1.85)
Five Day Return
(4.29)
Year To Date Return
(18.21)
Ten Year Return
(68.68)
All Time Return
3.8 K
Last Split Factor
3:1
Last Split Date
2001-01-18
1
Biogen Advances SMA Treatment to Key Study Phase BIIB Stock News
06/25/2025
2
Amyotrophic Lateral Sclerosis Competitive Intelligence Insight into Next-Gen Therapies DataM Intelligence
07/02/2025
3
Stoke Therapeutics, Biogen present data from EMPEROR study STOKBIIB
07/10/2025
4
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
07/15/2025
5
Satellos Appoints Dr. Wildon Farwell as Chief Medical Officer
07/16/2025
6
Parcion Private Wealth LLC Buys New Position in Biogen Inc.
07/17/2025
7
Edgestream Partners L.P. Sells 3,285 Shares of Biogen Inc.
07/18/2025
Begin Period Cash FlowB
Total Cashflows From Investing Activities-799.2 M

Biogen Relative Risk vs. Return Landscape

If you would invest  11,817  in Biogen Inc on April 23, 2025 and sell it today you would earn a total of  968.00  from holding Biogen Inc or generate 8.19% return on investment over 90 days. Biogen Inc is currently generating 0.1459% in daily expected returns and assumes 1.9591% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Biogen, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Biogen is expected to generate 1.31 times less return on investment than the market. In addition to that, the company is 2.53 times more volatile than its market benchmark. It trades about 0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.25 per unit of volatility.

Biogen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biogen Inc, and traders can use it to determine the average amount a Biogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0745

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskBIIBHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.96
  actual daily
17
83% of assets are more volatile

Expected Return

 0.15
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Biogen is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biogen by adding it to a well-diversified portfolio.

Biogen Fundamentals Growth

Biogen Stock prices reflect investors' perceptions of the future prospects and financial health of Biogen, and Biogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biogen Stock performance.

About Biogen Performance

By analyzing Biogen's fundamental ratios, stakeholders can gain valuable insights into Biogen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biogen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biogen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 388.71  201.06 
Return On Tangible Assets 0.14  0.08 
Return On Capital Employed 0.10  0.08 
Return On Assets 0.06  0.06 
Return On Equity 0.10  0.10 

Things to note about Biogen Inc performance evaluation

Checking the ongoing alerts about Biogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 93.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: Edgestream Partners L.P. Sells 3,285 Shares of Biogen Inc.
Evaluating Biogen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Biogen's stock performance include:
  • Analyzing Biogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biogen's stock is overvalued or undervalued compared to its peers.
  • Examining Biogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Biogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biogen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Biogen's stock. These opinions can provide insight into Biogen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Biogen's stock performance is not an exact science, and many factors can impact Biogen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals